| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5685700 | American Journal of Kidney Diseases | 2017 | 10 Pages |
Abstract
Tolvaptan decreased the incidence of kidney pain events independent of patient characteristics predisposing for kidney pain and possibly in part due to reductions in ADPKD-related complications.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Niek F. MD, Jaime D. PhD, Arlene B. MD, PhD, Frank S. MD, PhD, Olivier MD, PhD, Eiji MD, Anna M. MD, PhD, John PhD, Ronald D. MD, Vicente E. MD, PhD, Ron T. MD, PhD,